Balloon sinuplasty versus FESS in chronic maxillary sinusitis
Not Applicable
Completed
- Conditions
- Health Condition 1: J320- Chronic maxillary sinusitis
- Registration Number
- CTRI/2017/08/009334
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 48
Inclusion Criteria
all cases of chronic maxillary sinusitis with failed medical treatment for more than 12 weeks
Exclusion Criteria
cases with associated polyposis
diabetes mellitus
previous nasal surgeries
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SNOT-20 score, size of maxillary sinus ostium at the end of surgery and after 12 weeks in millimetresTimepoint: SNOT-20 score, size of maxillary sinus ostium at the end of surgery and after 12 weeks in millimetres
- Secondary Outcome Measures
Name Time Method balloon sinuplasty will be proven non inferior to endoscopic middle meatal antrostomyTimepoint: 1 year
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie chronic maxillary sinusitis pathogenesis and treatment response?
How does balloon sinuplasty compare to endoscopic middle meatal antrostomy in managing chronic maxillary sinusitis long-term outcomes?
Are there specific biomarkers that predict successful outcomes for balloon sinuplasty versus FESS in J320 sinusitis patients?
What are the potential adverse events associated with balloon sinuplasty compared to traditional endoscopic sinus surgery?
How do combination approaches involving balloon sinuplasty and medical therapies compare to standalone FESS for chronic maxillary sinusitis?